concept

JAK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about JAK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1531Connections
3Hypotheses
0Analyses
50Outgoing
50Incoming
0Experiments
0Debates

Summary

JAK is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, inhibits. Associated with ALS, Aging, Als. Connected to 853 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameJAK
Key Genes/ProteinsABCB1, ABCG2, ABL1, ACHE, AD, AD RISK GENES
Related DiseasesAddiction, aging, Aging
Related PathwaysAdaptive Immunity, Akt
Linked Hypotheses4 hypotheses

Wiki Pages (13)

Knowledge base pages for this entity

Canonical Page

JAK-STAT Signaling Pathway in Neurodegeneration

mechanism · 3502 words

JAK-STAT and Cytokine Signaling in 4R-Tauopathies

mechanism · 2596 words

JAK-STAT Signaling in Parkinson's Disease

mechanism · 2042 words

JAK2 Gene - Janus Kinase 2

gene · 1749 words

JAK3 Gene

gene · 1443 words

JAK-STAT Signaling Pathway in Neurodegeneration

mechanism · 1227 words

Pathway Diagram

graph TD
    JAK["JAK"]
    JAK -->|"activates"| STAT3["STAT3"]
    JAK -->|"regulates"| GENE_EXPRESSION["GENE_EXPRESSION"]
    JAK -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    JAK -->|"target for"| Cardiovascular["Cardiovascular"]
    JAK -->|"target for"| Inflammation["Inflammation"]
    JAK -->|"target for"| Als["Als"]
    JAK -->|"target for"| Cancer["Cancer"]
    JAK -->|"target for"| Ms["Ms"]
    IL6["IL6"] -->|"activates"| JAK
    SOCS["SOCS"] -->|"inhibits"| JAK
    STAT3 -->|"activates"| JAK
    CD4["CD4"] -->|"target for"| JAK
    BCL2["BCL2"] -->|"target for"| JAK
    VIRAL_INFECTIONS["VIRAL INFECTIONS"] -->|"activates"| JAK
    STAT2["STAT2"] -->|"inhibits"| JAK
    MTOR["MTOR"] -->|"target for"| JAK

Outgoing (1030)

TargetRelationTypeStr
Nf-Κbactivatespathway1.00
Alstherapeutic_targetdisease1.00
Inflammationactivatesdisease1.00
Canceractivatesdisease1.00
Tumortherapeutic_targetdisease1.00

Incoming (501)

SourceRelationTypeStr
h-cb2065e26ctargetshypothesis1.00
INFLAMMATIONtherapeutic_targetgene1.00
IL-6therapeutic_targetgene1.00
STAT3therapeutic_targetgene1.00
INFLAMMATIONactivatesgene1.00

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
H2: SASP Neutralization via JAK/STAT Inhibition Preserves As 0.550 neurodegeneration Do APOE4-driven senescent astrocytes cau
CNTF-JAK/STAT3 Reprogramming of Trained Microglia to Neuropr 0.522 neuroinflammation What specific astrocyte-derived factors
α4β1 Integrin (VLA-4) and JAK/STAT Pathway 0.450 neuroinflammation What molecular mechanisms mediate SPP1-i

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning JAK in their description or question text

No additional research found